✦ LIBER ✦

PRP16 COST-EFFECTIVENESS OF BUPROPION SR IN THE TREATMENT OF TOBACCO DEPENDENCE

✍ Scribed by J Wcislo; M Slawik; P Sas; K Landa; R Plisko; CA Glogowski; JM Gierczynski

Book ID: 119592912
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 68 KB
Volume: 6
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)61991-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bupropion SR for the treatment of smokel

Bupropion SR for the treatment of smokeless tobacco use

✍ Lowell C. Dale; Jon O. Ebbert; Elbert D. Glover; Ivana T. Croghan; Darrell R. Sc 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 356 KB

PMH43: THE COST-UTILITY OF BUPROPION SR

PMH43: THE COST-UTILITY OF BUPROPION SR VERSUS SERTRALINE IN THE TREATMENT OF LATE-LIFE DEPRESSION

✍ KL Suter; A Biddle 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

A Preliminary Trial: Double-Blind Compar

A Preliminary Trial: Double-Blind Comparison of Nefazodone, Bupropion-SR, and Placebo in the Treatment of Cannabis Dependence

✍ Kenneth M. Carpenter; David McDowell; Daniel J. Brooks; Wendy Y. Cheng; Frances 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 116 KB

Continuation phase treatment with buprop

Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression

✍ Karen L Weihs; Trisha L Houser; Sharyn R Batey; John A Ascher; Carolyn Bolden-Wa 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Long-term treatment with bupropion SR ef

Long-term treatment with bupropion SR effectively prevents the relapse and recurrence of depression

✍ K. Weihs; C. Bolden-Watson; T.L. Houser; S.R. Batey; J.A. Ascher; N.E. Richard; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Bupropion SR in the naturalistic treatme

Bupropion SR in the naturalistic treatment of elderly patients with major depression

✍ David C. Steffens; P. Murali Doraiswamy; Douglas R. McQuoid 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

## Abstract ## Introduction Bupropion immediate release (IR) and bupropion sustained release (SR) are frequently used to treat geriatric depression, as they have few cardiovascular, gastrointestinal and sexual adverse effects. We sought to examine the efficacy and dosing patterns of bupropion in a